Bridge­Bio on­col­o­gy spin­out to go pub­lic via com­bi­na­tion with SPAC from Cor­morant and Bi­hua Chen

The sec­ond blank-check ve­hi­cle from Cor­morant’s Bi­hua Chen plans to take Bridge­Bio’s on­col­o­gy spin­out on­to the Nas­daq.

The spe­cial pur­pose ac­qui­si­tion com­pa­ny — known as He­lix …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER